Global Peripheral Drug-eluting Balloon Market Growth 2025-2031

The global Peripheral Drug-eluting Balloon market size is predicted to grow from US$ 731 million in 2025 to US$ 1431 million in 2031; it is expected to grow at a CAGR of 11.9% from 2025 to 2031.

United States market for Peripheral Drug-eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Peripheral Drug-eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Peripheral Drug-eluting Balloon is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Peripheral Drug-eluting Balloon players cover Medtronic, Boston Scientific, Terumo Corporation, Acotec, BD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Peripheral Drug-eluting Balloon Industry Forecast” looks at past sales and reviews total world Peripheral Drug-eluting Balloon sales in 2024, providing a comprehensive analysis by region and market sector of projected Peripheral Drug-eluting Balloon sales for 2025 through 2031. With Peripheral Drug-eluting Balloon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Drug-eluting Balloon industry.

This Insight Report provides a comprehensive analysis of the global Peripheral Drug-eluting Balloon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral Drug-eluting Balloon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peripheral Drug-eluting Balloon market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Drug-eluting Balloon and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Drug-eluting Balloon.

This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Drug-eluting Balloon market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Paclitaxel

Others

Segmentation by Application:

Lower Limbs

Renal Artery

Carotid Artery

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Medtronic

Boston Scientific

Terumo Corporation

Acotec

BD

Surmodics

Biotronik

Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.

Zylox-Tonbridge Medical Technology Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Peripheral Drug-eluting Balloon market?

What factors are driving Peripheral Drug-eluting Balloon market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Peripheral Drug-eluting Balloon market opportunities vary by end market size?

How does Peripheral Drug-eluting Balloon break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.